The report found that 616 deals of more than $1 million flew "under the radar" of antitrust reporting requirements between 2010 and 2019.
The FTC says Richard Fairbank failed to comply with requirements of the Hart-Scott-Rodino Act when he acquired Capital One shares in 2018.
MedMen is opting out of a transaction with Pharmacann as it increases its focus on profitability, says CEO Adam Bierman.
When an M&A transaction is flagged for a deeper regulatory review, the buyer and seller may be faced with significant challenges.
The activist fund allegedly failed to comply with premerger notification rules before acquiring stock in DowDuPont two years ago.
The companies allegedly structured a deal so it would not be delayed by U.S. pre-merger notification laws.
ValueAct failed to notify regulators that it purchased stock in Baker Hughes and Halliburton after the two companies proposed a merger, says the DOJ.
Equity grants could trigger financial penalties for executives and directors.
